Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

long term pfizer vaccine elicited sars cov 2 antibody profile in breast milk

Sumary of Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk:

  • Even as the overall safety of the coronavirus disease 2019 (COVID-19) vaccines in pregnant women appears to be supported by available post-vaccination data, a new study published on the preprint server medRxiv* appears to indicate that the Pfizer vaccine induces antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
  • Study: Quantification and progress over time of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with BNT162b2 Pfizer-BioNTech COVID-19 vaccine (LacCOVID).
  • The authors of the current study also analyzed vaccine efficacy and adverse reactions associated with vaccination in mothers or infants.
  • This is the first long-term study on breast milk antibody titers following the administration of this vaccine.
  • The current study included 33 mother-infant pairs, at a median age of 38 years for the mothers and 15 months for the infants.
  • None of the study participants tested positive for the infection at the beginning of the study.
  • Altogether, there were 149 serum and milk samples each, the first set being taken at a median of two weeks from the first dose, and the second at 14 days from the second dose.
  • Study findings The investigators found that at two weeks from the second dose, the median anti-spike S1 immunoglobulin G (IgG) antibody levels were highest in both serum and milk, following a parallel course from the earliest time point in their rise and fall, though separated by a large margin.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.